Chondroitin and Mobility decreased - a phase IV clinical study of FDA data

Summary:

Mobility decreased is reported as a side effect among people who take Chondroitin (chondroitin sulfate), especially for people who are female, 60+ old, also take Euthyrox, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Mobility decreased when taking Chondroitin. It is created by eHealthMe based on reports of 3,822 people who have side effects when taking Chondroitin from the FDA, and is updated regularly.

What is Chondroitin?

Chondroitin has active ingredients of chondroitin sulfate. eHealthMe is studying from 3,959 Chondroitin users. Check the latest studies of Chondroitin.

What is Mobility decreased?

Mobility decreased (ability to move is reduced) is found to be associated with 1,776 drugs and 1,632 conditions by eHealthMe. Check the latest studies of Mobility decreased.

On Jul, 16, 2026

3,822 people reported to have side effects when taking Chondroitin.
Among them, 85 people (2.22%) have Mobility decreased.

Could Chondroitin cause Mobility decreased?

Among these 85 people:

What is the gender of people who have Mobility decreased when taking Chondroitin? *

female: 87.06 %
male: 12.94 %

What is the age of people who have Mobility decreased when taking Chondroitin? *

What are other drugs people take besides Chondroitin? *

What are other side effects people have besides Mobility decreased? *

Dizziness: 55 people, 64.71%
Stress And Anxiety: 49 people, 57.65%
Nausea (feeling of having an urge to vomit): 49 people, 57.65%
High Blood Pressure: 48 people, 56.47%
Fall: 45 people, 52.94%
General Physical Health Deterioration (weak health status): 42 people, 49.41%
Hypokalemia (low potassium): 40 people, 47.06%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 38 people, 44.71%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 38 people, 44.71%
Head Discomfort: 35 people, 41.18%

What are the existing conditions these people have? *

High Blood Pressure: 45 people, 52.94%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 45 people, 52.94%
Pain: 43 people, 50.59%
Constipation: 38 people, 44.71%
Post Herpetic Neuralgia (neuralgia caused by the varicella zoster virus): 31 people, 36.47%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 31 people, 36.47%
Nausea (feeling of having an urge to vomit): 31 people, 36.47%
Encephalopathy (functioning of the brain is affected by some agent or condition): 31 people, 36.47%
Calcium Deficiency (lack of calcium): 31 people, 36.47%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 30 people, 35.29%

* Approximation only. Some reports may have incomplete information.

Do you take Chondroitin and have Mobility decreased?

- Check whether Mobility decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Chondroitin:

Chondroitin (3,959 reports)

Browse all side effects of Chondroitin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Mobility decreased:

Mobility decreased (1,776 drugs)

Browse all the conditions that are associated with Mobility decreased:

Mobility decreased (1,632 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on chondroitin sulfate (the active ingredients of Chondroitin) and Chondroitin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.